|
NUP160 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.22044604925031E-16 |
| Normal-vs-Stage2 |
5.11209963249826E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.63691282750733E-12 |
| Stage1-vs-Stage2 |
5.128400E-01 |
| Stage1-vs-Stage3 |
1.034170E-02 |
| Stage1-vs-Stage4 |
7.642500E-03 |
| Stage2-vs-Stage3 |
2.570200E-01 |
| Stage2-vs-Stage4 |
1.071990E-01 |
| Stage3-vs-Stage4 |
5.152000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.14970000000215E-05 |
| Normal-vs-Asian |
2.56709997703553E-09 |
| Caucasian-vs-AfricanAmerican |
2.310600E-01 |
| Caucasian-vs-Asian |
5.259400E-01 |
| AfricanAmerican-vs-Asian |
5.495400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
1.887840E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.68265401612189E-12 |
| Normal-vs-Age(41-60Yrs) |
3.33066907387547E-16 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
4.31770000000053E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.122580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.615100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.835030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.335990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.485800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.195800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.909810E-02 |
| Classical-VS-Follicular |
3.753500E-02 |
| Classical-VS-Other |
5.586600E-01 |
| Classical-VS-Normal |
9.55240331279583E-11 |
| Tall-VS-Follicular |
3.209000E-01 |
| Tall-VS-Other |
5.133000E-01 |
| Tall-VS-Normal |
1.79833925528783E-12 |
| Follicular-VS-Other |
9.149400E-01 |
| Follicular-VS-Normal |
1.70818914568827E-12 |
| Other-VS-Normal |
1.296330E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
3.75921516138078E-13 |
| N0-vs-N1 |
3.697600E-01 |
|
|
